Related Experiment Video
Updated: May 11, 2025

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
Early Sodium Bicarbonate Use in Pediatric In-Hospital Cardiac Arrest: A Single-Center, Retrospective Cohort Study,
Nicole A Duster1, Anne V Grossestreuer2, Jill L Sorcher3
1Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Early use of sodium bicarbonate (SB) during pediatric in-hospital cardiac arrest (p-IHCA) was not associated with improved survival or return of spontaneous circulation (ROSC). These findings suggest a need to re-evaluate current guidelines for SB administration in p-IHCA.
Area of Science:
- Pediatric Critical Care Medicine
- Emergency Medicine
- Cardiology
Background:
- Sodium bicarbonate (SB) is sometimes used during pediatric in-hospital cardiac arrest (p-IHCA).
- The optimal timing for SB administration in p-IHCA remains unclear.
- Previous studies have not definitively established the impact of early SB on patient outcomes.
Purpose of the Study:
- To investigate the association between the timing of SB administration and outcomes in pediatric patients experiencing in-hospital cardiac arrest (p-IHCA).
- To determine if administering SB within the first 5 minutes of p-IHCA improves the likelihood of hospital survival and return of spontaneous circulation (ROSC).
Main Methods:
- A retrospective cohort study was conducted at a quaternary care academic children's hospital.
- Included were pediatric patients (≤18 years) with pulseless IHCA lasting at least 5 minutes between January 2013 and January 2023.
- Logistic treatment-effects estimation with inverse-probability weighting was used to compare outcomes between early SB (<5 minutes) and no early SB groups.
Main Results:
- Of 243 p-IHCA events, 41% received SB within the first 5 minutes of cardiopulmonary resuscitation (CPR).
- Overall survival to discharge was 44%, and ROSC was achieved in 37% of patients.
- Early SB administration was not significantly associated with improved adjusted odds of survival to discharge (aOR, 0.87) or ROSC (aOR, 0.82).
Conclusions:
- This study found no association between the timing of SB administration and survival or ROSC in pediatric patients with IHCA.
- The findings suggest that current U.S. national guidelines for SB use during p-IHCA may need reevaluation.
- Further research is warranted to clarify the role and optimal use of SB in pediatric resuscitation.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Roles of Electrolytes: Chloride and Bicarbonate
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
Bicarbonate-Carbonic Acid Buffer
Disorders of Acid-Base Balance
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...

